Table 4. Comparisons of demographic characteristics for successful and failed treatments of methotrexate injection.
Success (N = 19) |
Failure (N = 12) |
p-value | |
---|---|---|---|
Systemic MTX* | 16‡ | 12 | 0.265 |
Gestational weeks† (mean ± SD) | 8.11 ± 1.82 | 9.50±2.27 | 0.070 |
Initial β-hCG level† (mean ± SD) | 39,905.0±47881.0 | 30,458.4±39,513.9 | 0.573 |
Sac size† (mm) (mean ± SD) | 31.6 ± 13.4 | 41.3 ± 13.0 | 0.040 |
Positive FHB* (N) | 6 | 5 | 0.705 |
Distance between CSP and uterine serosa† (mean± SD) | 1.31 ± 2.08 | 2.83 ± 2.70 | 0.088 |
* Chi-Square test
† Independent t test
‡ The other 3 patients received MTX local injection into the GS.
FHB: fetal heartbeat, CSP: cesarean scar pregnancy